Friday, May 24, 2019
wellness India Expo
Home Tags Pharma

Tag: Pharma

Jubilant Life Sciences YoY revenue up by 21% at 9,111 crore

While the company recorded the year on year revenue growth up to 21 percent standing ar Rs 9,111 crore and EBITDA up by 14% to Rs 1,775 crore. The normalized PAT stood at Rs 855 crore. During the fourth quarter, revenue was Rs 2,386 crore and normalized PAT was at Rs 135 Crore................

Takeda announces Andrey Potapov as ICMEA Area Head

Potapov’s appointment follows Takeda’s recent acquisition of Shire Pharmaceuticals – enabling Takeda to become a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan...............

Cipla appoints Dr Raju Mistry as Global Chief People Officer

In her role at Cipla, Raju will oversee Human Resources, and Administration and Facilities Management......................

Experts discuss various aspects of phytopharmaceutical industry in India

Jamia Hamdard, New Delhi in collaboration with CSIR-IIIM Jammu organized a session on ‘Phytopharmaceuticals: Development, Regulatory, IPR & Marketing Challenges’..................

Lupin Bioresearch Centre completes fifth successful US-FDA inspection

Lupin Bioresearch Centre (LBC) conducts the in-vivo and in-vitro bioequivalence studies for Lupin in Pune...................

SCHOTT KAISHA to expand its operations in Gujarat & North India

The Indo-German joint venture recently held five city roadshows that hosted more than 500 customers, partners and prospects under one roof in Chandigarh, Ahmedabad, Mumbai, Bangalore and Hyderabad...……….

World class drugs with unwavering quality is need of the hour:...

Mr M. Venkaiah Naidu urged the Indian pharmaceutical industry to remain committed to high standards of quality in drug manufacturing and quality frameworks.................

DBT invites comments on draft guidelines for evaluation of nanopharmaceuticals

The Department of Biotechnology (DBT) has invited comments on “Guidelines for evaluation of nanopharmaceuticals in India” from the institutions, industry and researchers upto 10th March..........

Illumina’s executive chairman talks about precision medicine at CORE Diagnostics meet

Mr Jay Flatley who serves as the Executive Chairman of the Board of Directors, Illumina emphasized on the need for large-scale population study with an Indian cohort as the much needed next step in understanding disease patterns that are specific to people of Indian origin...……...

4677 generic medicine centres made functional by the end of 2018

As per the union government, unbranded generic medicines worth Rs 417 crores (MRP) have been sold through 4677 ‘Pradhan Mantri Bhartiya Jan Aushadhi Pariyojana’ (PMBJP) Kendras that are functional in 35 States/UTs of the country...………..